StemCell Institute

7096.TPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥2.8bn—Operating income¥203m—Net income (owners)¥156m—Total assets¥8.1bn—EPS (basic)¥15.44—

Full financial history and reports →

Stock price7096 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Mar 3 · JST1 filing

16:005% STAKEStemCell Institute · NIHON TRIM CO., LTD. · 72.06% → 70.02%−2.04pp

Tue, Feb 4 · JST3 filings

15:59MATERIALStemCell Institute · Change in major shareholder 12:315% STAKEStemCell Institute · NIHON TRIM CO., LTD. · 72.06%new 72.06%12:265% STAKEStemCell Institute · Trim Medical Holdings Inc. · 72.57% → 0.00%−72.57pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
NIHON TRIM CO., LTD.	70.02%	-2.04pp	2025-03-03

Each holder's own ratio from its most recent large-shareholding report.